MedPath

Mid-Atlantic Epilepsy and Sleep Center, LLC

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

9

Active:0
Completed:2

Trial Phases

5 Phases

Phase 1:1
Phase 2:3
Phase 3:1
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)β€’ Click on a phase to view related trials

Phase 2
3 (42.9%)
Not Applicable
1 (14.3%)
Phase 1
1 (14.3%)
Phase 3
1 (14.3%)
Phase 4
1 (14.3%)

Cortical Excitability in Post-traumatic Epilepsy

Recruiting
Conditions
Epilepsy
Traumatic Brain Injury
Cortical Excitability
First Posted Date
2022-08-26
Last Posted Date
2022-08-26
Lead Sponsor
Mid-Atlantic Epilepsy and Sleep Center, LLC
Target Recruit Count
30
Registration Number
NCT05517954
Locations
πŸ‡ΊπŸ‡Έ

Mid-Atlantic Epilepsy and Sleep center, Bethesda, Maryland, United States

Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy

Conditions
Focal Epilepsy
First Posted Date
2021-05-10
Last Posted Date
2022-08-11
Lead Sponsor
Mid-Atlantic Epilepsy and Sleep Center, LLC
Target Recruit Count
100
Registration Number
NCT04879433
Locations
πŸ‡ΊπŸ‡Έ

Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland, United States

Treatment of Type 2 Diabetes With Ketogenic Diet

Not Applicable
Conditions
Obesity
Type2 Diabetes Mellitus
First Posted Date
2018-08-29
Last Posted Date
2018-08-29
Lead Sponsor
Mid-Atlantic Epilepsy and Sleep Center, LLC
Target Recruit Count
50
Registration Number
NCT03652649
Locations
πŸ‡ΊπŸ‡Έ

Ivana Tyrlikova, Bethesda, Maryland, United States

Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.

Phase 4
Terminated
Conditions
Epilepsy
Interventions
First Posted Date
2016-04-04
Last Posted Date
2017-08-29
Lead Sponsor
Mid-Atlantic Epilepsy and Sleep Center, LLC
Target Recruit Count
8
Registration Number
NCT02727101
Locations
πŸ‡ΊπŸ‡Έ

MidAtlantic Epilepsy and Sleep Center, Bethesda, Maryland, United States

Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus

Phase 3
Withdrawn
Conditions
Status Epilepticus
Epilepsy
Interventions
First Posted Date
2016-04-04
Last Posted Date
2017-08-29
Lead Sponsor
Mid-Atlantic Epilepsy and Sleep Center, LLC
Registration Number
NCT02726867
Locations
πŸ‡ΊπŸ‡Έ

MidAtlantic Epilepsy and Sleep Center, Bethesda, Maryland, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.